FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071191 [Registered on: 24/07/2024] Trial Registered Prospectively
Last Modified On: 22/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of inhaled Dexmedetomidine ( this is a drug used to manage pain and sedation in the icu and operating theatre) and Lignocaine (this is a drug used to prevent pain) on blood pressure, heart rate, oxygen saturation during intubation.  
Scientific Title of Study   Comparative evaluation of nebulised Dexmedetomidine and Lignocaine on haemodynamic stress response to laryngoscope and intubation - A prospective, randomized clinical study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Tridha Ghosh 
Designation  Post Graduation Student 
Affiliation  Gajra Raja Medical College, Gwalior, MadhyaPradesh 
Address  Jaya Arogya Hospital,Campus, Lashkar, Gwalior. Block C- 7th floor, Anaesthesia Department. Room no.701.

Gwalior
MADHYA PRADESH
474009
India 
Phone  9903377851  
Fax    
Email  tridhaghosh@yahoo.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jitendra Agrawal 
Designation  Professor 
Affiliation  Gajra Raja Medical College, Gwalior,Madhya Pradesh 
Address  Jaya Arogya Hospital, Campus,Lashkar,Gwalior, Department- Anaesthesia, block C, 7th floor, Room no. 702

Gwalior
MADHYA PRADESH
474009
India 
Phone  9300009942  
Fax    
Email  drjagrawal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Jitendra Agrawal 
Designation  Professor 
Affiliation  Gajra Raja Medical College, Gwalior,Madhya Pradesh 
Address  Jaya Arogya Hospital, Campus,Lashkar,Gwalior, department of Anaesthesia, 7th floor, Block C , Room no. 702

Gwalior
MADHYA PRADESH
474009
India 
Phone  9300009942  
Fax    
Email  drjagrawal@gmail.com  
 
Source of Monetary or Material Support  
Gajra Raja Medical College, Veer Savakar Marg, Gwalior, Madhya Pradesh. Pincode-474009 
 
Primary Sponsor  
Name  Dr Tridha Ghosh 
Address  Jaya Arogya Hospital Campus, Lashkar, Gwalior, Madhya Pradesh 474009 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tridha Ghosh  Jaya Arogya Hospital   Anaesthesiology Department,Block C , 7th floor, OT complex, Room 7A, Lashkar,Gwalior, Madhya Pradesh 474009
Gwalior
MADHYA PRADESH 
9903377851

tridhaghosh@yahoo.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee (IEC) GAJRA RAJA MEDICAL COLLEGE, GWALIOR, M.P  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nebulized Dexmedetomidine  Patient Will be receiving nebulized Dexmedetomidine 1 microgram per kg mixed with saline to a total volume of 5ml 
Comparator Agent  Nebulized Lignocaine   Patient Will be receiving nebulized Lignocaine 4mg/kg with a nebuliser face mask and a continuous flow of 100 percent oxygen at 6L/min for 10mins before induction of anaesthesia  
Comparator Agent  Normal Saline  Patient Will be receiving 5 ml normal saline with a nebu.izer face mask with a continuous flow of 100% oxygen at 6l/ min for 10 mins before intubation.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Patient giving consent to participate in study
2) Age between 18-60yrs
3) American Society of Anaesthesiologist Grade 1 & 2 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
1) Dexmedetomidine (1microgram/kg) serves as a very useful anaesthesia adjuvant to control haemodynamic stress response to laryngoscope and intubation without any significant adverse effects.
2) Efficacy of nebulized dexmedetomidine in attenuation of the haemodynamic stress response compared to nebulized Lignocaine will be significantly higer in ASA-1 and 2 Patients with respect to HR, SBP, DBP and MAP.

 
These outcomes are based on observations made after giving nebulized drugs 10 minutes before intubation to 90th minutes intraoperatively. 
 
Secondary Outcome  
Outcome  TimePoints 
Nebulized Lignocaine also attenuated the haemodynamic stress response during intubation and laryngoscopy compared to normal saline.  These outcomes are based on observations made after giving nebulized drugs 10 minutes before intubation to 90th minutes intraoperatively. 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
The Study ’ Comparative evaluation of nebulized Dexmedetomidine and Lignocaine on haemodynamic stress response to laryngoscopy and intubation-A prospective, randomized clinical study.’ Will be done in Gajra Raja Medical College, Gwalior MP on sample size of 60 Patients for the time period of 8 months after fulfilling the eligibility criteria will be chosen by simple randomization.Patients will be subsequently randomized into 3 groups by closed enveloped technique. Group D- Patient Will be receiving nebulized Dexmedetomidine 1mjcrogram/kg.
Group L- will be receiving nebulized Lignocaine 4mg/kg. Group C- will be receiving normal saline 5ml. The Patient Will be kept under observation after intubation for noting the vital parameters
like heart rate, blood pressure ( Systolic SBP and Diastolic DBP) , mean arterial pressure, pulse oximetry (spo2) at the following time points: baseline,after nebulization,post larygoscopy/intubation at 1,5,10,20,30,40,50,60 and 90mins. After the study end, results will be obtained. Primary aim of this study is to evaluate the role of nebulized dexmedetomidine as a premedication in attenuation the stress response to larygoscopy and intubation and to compare it with nebulized Lignocaine.










 
Close